147 related articles for article (PubMed ID: 9727002)
1. Effect of insulin on farnesyltransferase. Specificity of insulin action and potentiation of nuclear effects of insulin-like growth factor-1, epidermal growth factor, and platelet-derived growth factor.
Goalstone ML; Leitner JW; Wall K; Dolgonos L; Rother KI; Accili D; Draznin B
J Biol Chem; 1998 Sep; 273(37):23892-6. PubMed ID: 9727002
[TBL] [Abstract][Full Text] [Related]
2. Dominant negative farnesyltransferase alpha-subunit inhibits insulin mitogenic effects.
Solomon CS; Goalstone ML
Biochem Biophys Res Commun; 2001 Jul; 285(2):161-6. PubMed ID: 11444820
[TBL] [Abstract][Full Text] [Related]
3. Dominant negative alpha-subunit of FTase inhibits effects of insulin and IGF-I in MCF-7 cells.
Solomon CS; Goalstone ML
Biochem Biophys Res Commun; 2002 Mar; 291(3):458-65. PubMed ID: 11855811
[TBL] [Abstract][Full Text] [Related]
4. NIH 3T3 cells transfected with a yeast H(+)-ATPase have altered sensitivity to insulin, insulin growth factor-I, and platelet-derived growth factor-AA.
Peterson EP; Martinez GM; Martinez-Zaguilan R; Perona R; Gillies RJ
J Cell Physiol; 1994 Jun; 159(3):551-60. PubMed ID: 8188769
[TBL] [Abstract][Full Text] [Related]
5. Hyperinsulinemia potentiates activation of p21Ras by growth factors.
Leitner JW; Kline T; Carel K; Goalstone M; Draznin B
Endocrinology; 1997 May; 138(5):2211-4. PubMed ID: 9112423
[TBL] [Abstract][Full Text] [Related]
6. Insulin stimulates the phosphorylation and activity of farnesyltransferase via the Ras-mitogen-activated protein kinase pathway.
Goalstone M; Carel K; Leitner JW; Draznin B
Endocrinology; 1997 Dec; 138(12):5119-24. PubMed ID: 9389491
[TBL] [Abstract][Full Text] [Related]
7. Insulin signals to prenyltransferases via the Shc branch of intracellular signaling.
Goalstone ML; Leitner JW; Berhanu P; Sharma PM; Olefsky JM; Draznin B
J Biol Chem; 2001 Apr; 276(16):12805-12. PubMed ID: 11278505
[TBL] [Abstract][Full Text] [Related]
8. Effect of insulin on farnesyltransferase activity in 3T3-L1 adipocytes.
Goalstone ML; Draznin B
J Biol Chem; 1996 Nov; 271(44):27585-9. PubMed ID: 8910345
[TBL] [Abstract][Full Text] [Related]
9. Effect of farnesyltransferase overexpression on cell growth and transformation.
Nagase T; Kawata S; Nakajima H; Tamura S; Yamasaki E; Fukui K; Yamamoto K; Miyagawa J; Matsumura I; Matsuda Y; Matsuzawa Y
Int J Cancer; 1999 Jan; 80(1):126-33. PubMed ID: 9935242
[TBL] [Abstract][Full Text] [Related]
10. GTP loading of farnesylated p21Ras by insulin at the plasma membrane.
Goalstone M; Leitner JW; Draznin B
Biochem Biophys Res Commun; 1997 Oct; 239(1):42-5. PubMed ID: 9345266
[TBL] [Abstract][Full Text] [Related]
11. Effect of insulin on farnesyltransferase gene transcription and mRNA stability.
Goalstone ML; Draznin B
Biochem Biophys Res Commun; 1999 Jan; 254(1):243-7. PubMed ID: 9920764
[TBL] [Abstract][Full Text] [Related]
12. Increased amounts of farnesylated p21Ras in tissues of hyperinsulinaemic animals.
Goalstone ML; Wall K; Leitner JW; Kurowski T; Ruderman N; Pan SJ; Ivy JL; Moller DE; Draznin B
Diabetologia; 1999 Mar; 42(3):310-6. PubMed ID: 10096783
[TBL] [Abstract][Full Text] [Related]
13. Dominant negative alpha-subunit of farnesyl- and geranylgeranyl-transferase I inhibits insulin-induced differentiation of 3T3-L1 pre-adipocytes.
Solomon CS; Leitner JW; Goalstone ML
Int J Obes Relat Metab Disord; 2003 Jan; 27(1):40-7. PubMed ID: 12532152
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the growth of murine fibroblasts that express human insulin receptors. II. Interaction of insulin with other growth factors.
Randazzo PA; Jarett L
Exp Cell Res; 1990 Sep; 190(1):31-9. PubMed ID: 2201553
[TBL] [Abstract][Full Text] [Related]
15. Signal transduction by a chimeric insulin-like growth factor-1 (IGF-1) receptor having the carboxyl-terminal domain of the insulin receptor.
Tartare S; Mothe I; Kowalski-Chauvel A; Breittmayer JP; Ballotti R; Van Obberghen E
J Biol Chem; 1994 Apr; 269(15):11449-55. PubMed ID: 8157675
[TBL] [Abstract][Full Text] [Related]
16. Prolonged vs transient roles for early cell cycle signaling components.
Rose DW; Xiao S; Pillay TS; Kolch W; Olefsky JM
Oncogene; 1998 Aug; 17(7):889-99. PubMed ID: 9780005
[TBL] [Abstract][Full Text] [Related]
17. Activation of the insulin-like growth factor-I receptor inhibits tumor necrosis factor-induced cell death.
Wu Y; Tewari M; Cui S; Rubin R
J Cell Physiol; 1996 Sep; 168(3):499-509. PubMed ID: 8816904
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-1 (IGF-1), insulin, and epidermal growth factor (EGF) are survival factors for density-inhibited, quiescent Balb/c-3T3 murine fibroblasts.
Tamm I; Kikuchi T
J Cell Physiol; 1990 Jun; 143(3):494-500. PubMed ID: 2193035
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor, epidermal growth factor, insulin-like growth factors, and platelet-derived growth factor-BB stimulate proliferation of clonally derived porcine myogenic satellite cells.
Doumit ME; Cook DR; Merkel RA
J Cell Physiol; 1993 Nov; 157(2):326-32. PubMed ID: 8227164
[TBL] [Abstract][Full Text] [Related]
20. Fetal hyperinsulinemia increases farnesylation of p21 Ras in fetal tissues.
Stephens E; Thureen PJ; Goalstone ML; Anderson MS; Leitner JW; Hay WW; Draznin B
Am J Physiol Endocrinol Metab; 2001 Aug; 281(2):E217-23. PubMed ID: 11440896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
